429
Views
27
CrossRef citations to date
0
Altmetric
Report

Helicobacter pylori DNA isolation in the stool: an essential pre-requisite for bacterial noninvasive molecular analysis

, , , , , , , , & show all
Pages 1429-1432 | Received 09 Jun 2016, Accepted 10 Jul 2016, Published online: 09 Aug 2016

References

  • Krishna NK, Cunnion KM. Role of molecular diagnostics in the management of infectious disease emergencies. Med Clin North Am. 2012;96:1067–1078.
  • Gullett JC, Nolte FS. Quantitative nucleic acid amplification methods for viral infections. Clin Chem. 2015;61:72–78.
  • Makristathis A, Hirschl AM, Lehours P, et al. Diagnosis of Helicobacter pylori infection. Helicobacter. 2004;9:7–14.
  • De Francesco V, Margiotta M, Zullo A, et al. Primary clarithromycin resistance in Italy assessed on Helicobacter pylori DNA sequences by TaqMan real-time polymerase chain reaction. Aliment Pharmacol Ther. 2006;23:429–435.
  • Zullo A, Hassan C, Lorenzetti R, et al. A clinical practice viewpoint: to culture or not to culture Helicobacter pylori? Dig Liver Dis. 2003;35:357–361.
  • Cammarota G, Ianiro G, Bibbò S, et al. Culture-guided treatment approach for Helicobacter pylori infection: review of the literature. World J Gastroenterol. 2014;20:5205–5211.
  • Zagari RM, Romano M, Ojetti V, et al. Guidelines for the management of Helicobacter pylori infection in Italy: the III Working Group Consensus Report 2015. Dig Liver Dis. 2015;47:903–912.
  • De Francesco V, Zullo A, Ierardi E, et al. Phenotypic and genotypic Helicobacter pylori clarithromycin resistance and therapeutic outcome: benefits and limits. J Antimicrob Chemother. 2010;65:327–332.
  • Monno R, Giorgio F, Carmine P, et al. Helicobacter pylori clarithromycin resistance detected by Etest and TaqMan real-time polymerase chain reaction: a comparative study. APMIS. 2012;120:712–717.
  • Wolle K, Leodolter A, Malfertheiner P, et al. Antibiotic susceptibility of Helicobacter pylori in Germany: stable primary resistance from 1995 to 2000. J Med Microbiol. 2002;51:705–709.
  • De Francesco V, Margiotta M, Zullo A, et al. Clarithromycin-resistant genotypes and eradication of Helicobacter pylori. Ann Intern Med. 2006;144:94–100.
  • Ierardi E, Giorgio F, Losurdo G, et al. How antibiotic resistances could change Helicobacter pylori treatment: A matter of geography? World J Gastroenterol. 2013;19:8168–8180.
  • Ierardi E, Margiotta M, Monno R, et al. A new semiquantitative method of quantifying Helicobacter pylori in antigen stools. J Clin Gastroenterol. 2002;35:375–378.
  • Ierardi E, Giorgio F, Losurdo G, et al. Detection of Helicobacter pylori DNA sequences in gastric biopsy samples to refine the diagnosis and therapy. J Med Microbiol. 2015;64:788–789.
  • De Francesco V, Margiotta M, Zullo A, et al. Prevalence of primary clarithromycin resistance in Helicobacter pylori strains over a 15 year period in Italy. J Antimicrob Chemother. 2007;59:783–785.
  • De Francesco V, Giorgio F, E I, et al. Primary clarithromycin resistance in Helicobacter pylori: the Multicentric Italian Clarithromycin Resistance Observational (MICRO) study. J Gastrointestin Liver Dis. 2011;20:235–239.
  • Neri V, Margiotta M, de Francesco V, et al. DNA sequences and proteic antigens of H. pylori in cholecystic bile and tissue of patients with gallstones. Aliment Pharmacol Ther. 2005;22:715–720.
  • Losurdo G, Leandro G, Principi M, et al. Sequential vs. prolonged 14-day triple therapy for Helicobacter pylori eradication: the meta-analysis may be influenced by 'geographical weighting'. Int J Clin Pract. 2015;69:1112–1120.
  • Ierardi E, Losurdo G, Giorgio F, et al. Quinolone-based first, second and third-line therapies for Helicobacter pylori. World J Pharmacol. 2015;4:274–280.
  • Georgopoulos SD, Papastergiou V, Karatapanis S. Treatment of Helicobacter Pylori infection: optimization strategies in a high resistance era. Expert Opin Pharmacother. 2015;16:2307–2317.
  • Gill P, Alvandi AH, Abdul-Tehrani H, et al. Colorimetric detection of Helicobacter pylori DNA using isothermal helicase-dependent amplification and gold nanoparticle probes. Diagn Microbiol Infect Dis. 2008;62:119–124.
  • Uribe R, Fujioka T, Ito A, et al. Sensitive detection of Helicobacter pylori in gastric aspirates by polymerase chain reaction. Kansenshogaku Zasshi. 1998;72:114–122.
  • Sugimoto M, Wu JY, Abudayyeh S, et al. Unreliability of results of PCR detection of Helicobacter pylori in clinical or environmental samples. J Clin Microbiol. 2009;47:738–742.
  • Quaglia NC, Normanno G, Dambrosio A, et al. Multiplex-touchdown PCR assay for the detection and genotyping of Helicobacter pylori from artificially contaminated sheep milk. J Food Prot. 2005;68:2136–2139.
  • De Francesco V, Zullo A, Giorgio F, et al. Change of point mutations in Helicobacter pylori rRNA associated with clarithromycin resistance in Italy. J Med Microbiol. 2014;63:453–457.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.